{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:08:17Z","timestamp":1784437697001,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ygyno.2020.06.496","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T17:38:18Z","timestamp":1594748298000},"page":"590-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening"],"prefix":"10.1016","volume":"158","author":[{"given":"Rifat","family":"Ara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabera","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahana","family":"Pervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umme","family":"Shahera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin Akter","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayada","family":"Fatema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monowara","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahana","family":"Nazneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2020.06.496_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.meegid.2018.04.029","article-title":"Prevalence of human papilloma virus with risk of cervical cancer among south Indian women: a genotypic study with meta-analysis and molecular dynamics of HPV E6 oncoprotein","volume":"62","author":"Akram Husain","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12974\/2309-6160.2017.04.1","article-title":"Elevated Homocysteine, an emerging biomarker for cervical cancer, a case-controlled study","volume":"4","author":"Ara","year":"2017","journal-title":"Global J. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.06.496_bb0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000497286","article-title":"Spontaneous regression of cervical intraepithelial Neoplasia 2: a meta-analysis","volume":"84","author":"Zhang","year":"2019","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0020","doi-asserted-by":"crossref","first-page":"h2372","DOI":"10.1136\/bmj.h2372","article-title":"HPV testing as a screen for cervical cancer","volume":"350","author":"Goodman","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ygyno.2020.06.496_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","article-title":"World Health Organization guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer","volume":"132","author":"Santesso","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"38","key":"10.1016\/j.ygyno.2020.06.496_bb0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/ijc.29877","article-title":"Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china","volume":"1","author":"Valdez","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2020.06.496_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/fmb.11.87","article-title":"Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts","volume":"6","author":"Sahasrabuddhe","year":"2011","journal-title":"Future Microbiol."},{"issue":"16","key":"10.1016\/j.ygyno.2020.06.496_bb0040","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9601","key":"10.1016\/j.ygyno.2020.06.496_bb0045","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.ygyno.2020.06.496_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"23","key":"10.1016\/j.ygyno.2020.06.496_bb0055","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening VS conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"14","key":"10.1016\/j.ygyno.2020.06.496_bb0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ygyno.2020.06.496_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and north American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.06.496_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0080","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1309\/84E5WHJQHK83BGQD","article-title":"Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting","volume":"124","author":"Carozzi","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.ygyno.2020.06.496_bb0095","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1128\/JCM.01275-09","article-title":"Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix","volume":"47","author":"Cattani","year":"2009","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2020.06.496_bb0100","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.06.496_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ygyno.2010.09.013","article-title":"Quantification of intracellular HPV E6\/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared with HPV DNA","volume":"120","author":"Coquillard","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.496_bb0110","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/JCM.00382-10","article-title":"Clinical performance of the PreTect HPV-proofer E6\/E7 mRNA assay in comparison with that of the hybrid capture 2 test for identification of women at risk of cervical cancer","volume":"48","author":"Ratnam","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.06.496_bb0115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2010.06.011","article-title":"Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results","volume":"119","author":"Reuschenbach","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.06.496_bb0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jviromet.2010.07.011","article-title":"HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway","volume":"169","author":"Sorbye","year":"2010","journal-title":"J. Virol. Methods"},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.496_bb0125","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.01863-08","article-title":"Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia","volume":"47","author":"Trope","year":"2009","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.ygyno.2020.06.496_bb0130","first-page":"1411","article-title":"Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen cervical cancer screening trial","volume":"20","author":"Wu","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2020.06.496_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0164892","article-title":"A low-cost HPV immunochromatographic assay to detect high-grade cervical intraepithelial neoplasia","volume":"11","author":"Mariano","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ygyno.2020.06.496_bb0140","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JCM.01315-10","article-title":"Feasibility study of a human papillomavirus E6 Oncoprotien test for diagnosis of cervical precancer and cancer","volume":"48","author":"Schweizer","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.06.496_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/LGT.0b013e3181f6c84d","article-title":"Association of elevated E6 Oncoprotein with grade of cervical Neoplasia using PDZ interaction-mediated prescription of E6","volume":"15","author":"Sellors","year":"2011","journal-title":"J. Lower Genital Tract Dis."},{"issue":"9","key":"10.1016\/j.ygyno.2020.06.496_bb0150","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1940-6207.CAPR-13-0091","article-title":"An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China","volume":"6","author":"Zhao","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0155","series-title":"Emerging and developing economies much more optimistic than rich countries about the future. October 9","author":"PEW Research Center Global Attitudes & Trends","year":"2014"},{"issue":"11","key":"10.1016\/j.ygyno.2020.06.496_bb0160","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1373\/clinchem.2006.072884","article-title":"A magnetic Immunochromatographic strip test for detection of human papillomavirus 16 E6","volume":"52","author":"Peck","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0165","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/ijc.28616","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women, Low Cost triage strategies for HPV-positive women","volume":"134","author":"Qiao","year":"2013","journal-title":"Int. J.Cancer"},{"key":"10.1016\/j.ygyno.2020.06.496_bb0170","first-page":"6251","article-title":"E6\/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population","volume":"14","author":"Shi","year":"2017","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.ygyno.2020.06.496_bb0175","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/0300060517736913","article-title":"Feasibility study of a human papillomavirus E6 and E7 Oncoprotein test for the diagnosis of cervical precancer and cancer","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ygyno.2020.06.496_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.31633","article-title":"Eight-type human papillomavirus E6\/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women","volume":"144","author":"Rezhak","year":"2019","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820323222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:49:41Z","timestamp":1758772181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820323222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0090825820323222"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.496","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}